Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Bass, Berry & Sims Ranked as Top 10% IP Litigation Firm

October 6, 2014

Bass, Berry & Sims was recognized in the BTI Litigation Outlook 2015 report for its IP Litigation practice. According to the report, corporate counsel ranked Bass, Berry & Sims in the top 10% of all law firms for IP Litigation. BTI surveyed more than 300 general counsel to compile the data and analyze current and future trends in litigation.

Bass, Berry & Sims' IP litigation practice has built upon the firm's long-standing successes in trademark, copyright and trade secret litigation by greatly expanding its patent and high technology IP litigation capabilities in recent years. With the recent additions of Terry Clark, Ron Sigworth and Jason Rockman in the Washington, D.C. office and Greg Parker in the Nashville office, the firm's IP litigation team collectively has extensive IP litigation experience in a wide spectrum of scientific and technical fields, including pharmaceuticals; medical devices; computer science; internet commerce; consumer electronics; telecommunications; automotive systems; healthcare; and many other general matters involving electrical, mechanical and chemical engineering. By bringing together experienced litigators and technical subject matter professionals from each of the firm's offices, the firm’s IP litigation practice has achieved substantial success in high-profile and high-stakes litigation across the country.

The team has had a number of recent successes related to IP litigation, including:


Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.